Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 116,800 shares at $102.38 ($12.0M) on 2025-07-21, disclosed to the SEC on 2025-07-23.
Scheduled sale ($12.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.38 | 32,090 | $3.3M | 27.4% |
| 2 | $102.38 | 32,090 | $3.3M | 27.4% |
| 3 | $103.03 | 26,310 | $2.7M | 22.6% |
| 4 | $103.03 | 26,310 | $2.7M | 22.6% |
| Total | $102.67 avg | 116,800 | $12.0M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-09 | $11.1M | — | Filing → |